Cresset Asset Management’s Biogen BIIB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$11M Buy
87,650
+85,690
+4,372% +$10.8M 0.05% 214
2025
Q1
$268K Buy
1,960
+619
+46% +$84.7K ﹤0.01% 1358
2024
Q4
$205K Sell
1,341
-5,533
-80% -$846K ﹤0.01% 1530
2024
Q3
$1.33M Sell
6,874
-3,274
-32% -$635K 0.01% 998
2024
Q2
$2.35M Buy
10,148
+950
+10% +$220K 0.01% 629
2024
Q1
$1.98M Sell
9,198
-1,168
-11% -$252K 0.01% 631
2023
Q4
$2.68M Buy
10,366
+4,298
+71% +$1.11M 0.02% 461
2023
Q3
$1.56M Sell
6,068
-683
-10% -$176K 0.01% 627
2023
Q2
$1.92M Buy
6,751
+5,401
+400% +$1.54M ﹤0.01% 535
2023
Q1
$375K Sell
1,350
-1,231
-48% -$342K 0.01% 566
2022
Q4
$599K Sell
2,581
-318
-11% -$73.8K 0.01% 394
2022
Q3
$775K Sell
2,899
-64
-2% -$17.1K 0.01% 407
2022
Q2
$602K Sell
2,963
-607
-17% -$123K 0.01% 501
2022
Q1
$752K Sell
3,570
-808
-18% -$170K 0.01% 484
2021
Q4
$1.05M Sell
4,378
-339
-7% -$81.3K 0.01% 441
2021
Q3
$1.34M Buy
4,717
+1,316
+39% +$372K 0.02% 313
2021
Q2
$1.18M Sell
3,401
-383
-10% -$133K 0.02% 313
2021
Q1
$1.06M Buy
3,784
+390
+11% +$109K 0.02% 286
2020
Q4
$831K Sell
3,394
-926
-21% -$227K 0.01% 278
2020
Q3
$1.23M Buy
4,320
+385
+10% +$109K 0.02% 211
2020
Q2
$1.05M Buy
3,935
+1,739
+79% +$465K 0.02% 203
2020
Q1
$695K Buy
2,196
+736
+50% +$233K 0.02% 237
2019
Q4
$433K Buy
1,460
+162
+12% +$48K 0.01% 326
2019
Q3
$302K Buy
+1,298
New +$302K 0.01% 385
2019
Q2
Sell
-974
Closed -$230K 614
2019
Q1
$230K Buy
974
+409
+72% +$96.6K 0.01% 343
2018
Q4
$170K Buy
+565
New +$170K 0.01% 236